- Solutions
Our solutions
- OverviewOur workflow solutions give you the data, tools, and insights to power every decision
- Strategic IntelligenceGet a complete view of strategic issues and stay ahead of emerging disruptive themes
- Sales IntelligenceOur workflow solutions give you the data, tools, and insights to power every decision
- Industry
- Platform
Our platform
Your powerful intelligence platform
Explore the fully comprehensive productivity and insights platform
- Company
We are GlobalData
The pedicle screw-based dynamic stabilization systems space across the seven major Asia-Pacific (APAC) markets of Australia, China, India, Japan, New Zealand, South Korea and Taiwan, is set to rise from $12.5 million in 2016 to $19.2 million by 2023, representing a compound annual growth rate (CAGR) of 6.3%, according to GlobalData, a recognized leader in providing business information and analytics.
Acute myeloid leukemia market to surpass $1.5 billion by 2026
The acute myeloid leukemia (AML) market across the seven major countries (7MM) of the US, France, Germany, Italy, Spain, the UK, and Japan, will more than triple from $406 million in 2016 to over $1.5 billion by 2026, representing a compound annual growth rate of 14%, according to GlobalData, a recognized leader in providing business information and analytics.
Retail banks will increasingly use artificial intelligence to help determine credit ratings
Artificial intelligence (AI) is anticipated to make a significant impact on the retail banking sector, such as using non-traditional data types to assign credit ratings to potential borrowers, according to GlobalData, a recognized leader in providing business information and analytics. The company’s latest report explains how technologies such as machine learning, predictive analytics, and natural […]
European interspinous process decompression market to surpass $30 million by 2023
The European interspinous process decompression (IPD) market, which covers 21 countries, is set to rise from $19.7 million in 2016 to around $30.3 million in 2023, representing a compound annual growth rate of 6.3%, according to GlobalData, a recognized leader in providing business information and analytics.
Global HER2-positive breast cancer market to approach $10 billion in 2025
The human epidermal growth factor receptor type 2 (HER2)-positive breast cancer market across the eight major countries of the US, France, Germany, Italy, Spain, the UK, Japan, and China, is set to rise from $6.4 billion in 2015 to $9.89 billion in 2025, representing a compound annual growth rate of 4.4%, according to GlobalData, a recognized leader in providing business information and analytics.
NASH webinar- Understand the NASH Market Landscape
Affecting more than 60 million people worldwide, and with no approved therapies, nonalcoholic steatohepatitis (NASH) presents a wealth of opportunities for drug developers. Join GlobalData's webinar "Understand the NASH Market Landscape" July 12th.
Smartphone shopping to overtake tablet spend by 2018, says GlobalData
Spend via smartphones will outperform spend via tablets, accounting for 51.5% of the mobile and tablet market in 2018, according to GlobalData, a recognized leader in providing business information and analytics.
Millennials are the most experimental consumers, with seniors least likely to try new products
The older we get, the less likely we are to want to experiment with novel flavors and fragrances, according to GlobalData, a recognized leader in providing business information and analytics.
Hemophilia A and B market to approach $8 billion by 2026
The combined market value for hemophilia A and B across the seven major countries of the US, France, Germany, Italy, Spain, the UK and Japan is set to rise from $6.7 billion in 2016 to almost $8.0 billion in 2026, representing a compound annual growth rate of 1.8%, according to GlobalData, a recognized leader in providing business information and analytics.
Heart failure market to surpass $16 billion by 2026 as Novartis’ drug Entresto triggers huge growth
The heart failure space across the seven key markets of the US, France, Germany, Italy, Spain, the UK and Japan is set to grow from $3.7 billion in 2016 to around $16.1 billion by 2026, representing an impressive compound annual growth rate of 15.7%, according to GlobalData, a recognized leader in providing business information and analytics.
Private banks in Australia need to up their game to seize the expat opportunity
The wealthy expat community in Australia is an attractive opportunity for wealth managers. However, increasingly stringent investment requirements under the Significant Investor Visa (SIV) mean that private banks have to work harder to compete successfully in countries with more favorable immigrations conditions, according to GlobalData, a recognized leader in providing business information and analytics.
Asia-Pacific drug delivery devices market set to leave North America behind by 2026
The drug delivery devices market in North America (United States, Canada and Mexico), which comprises approximate 50% of the global market, grew at a compound average growth rate (CAGR) of 2.6% from 2010 to 2016. However, the Asia-Pacific (APAC) region showed a highest growth with a CAGR of 3.4% during the same period, according to GlobalData, a recognized leader in providing business information and analytics.
Reforms are driving pension savings and changing how pensions are taken in the UK
The UK’s pre- and post-retirement pension markets have recently seen some of the biggest legislative changes for a century, which have begun to drive growth in pension savings and change how individuals are choosing to access their pension pots, according to the latest report by GlobalData.
Poland’s pharmaceuticals market to see steady growth, reaching $11 billion by 2021
The Polish pharmaceutical industry is set to rise from $9.4 billion in 2016 to around $11 billion by 2021, representing a compound annual growth rate of 32%, according to GlobalData, a recognized leader in providing business information and analytics.
Brazil’s highly attractive pharmaceutical market to approach $30 billion by 2021
The Brazilian pharmaceutical market is set to grow from $25.3 billion in 2016 to $29.9 billion in 2021, representing a compound annual growth rate of 3.5%, according to GlobalData, a recognized leader in providing business information and analytics.
Pet food innovation mimicking human trends of snacking and clean eating
A majority of pet owners tend to liken their animals’ needs to their own, meaning recent consumer developments such as ‘clean eating’ and snacking trends are being integrated into the diets of cats, dogs, and other popular pets, according to GlobalData, a recognized leader in providing business information and analytics.
Political and economic events led to a slowdown in global financial deal activity in Q1 2017
The global financial services industry registered a decline in overall deal activity, with the number of deals falling from 587 in Q4 2016 to 561 in Q1 2017 according to GlobalData, a recognized leader in providing business information and analytics.
Singapore’s pharmaceutical market set to break $1 billion mark by 2019
The pharmaceutical market in Singapore is set to rise from $948 million in 2017 to around $1.2 billion in 2021, and will first exceed the $1 billion mark in 2019, according to GlobalData, a recognized leader in providing business information and analytics.
Older consumers yet to be convinced by the benefits of smart-tech solutions
While 73% of millennials find the concept of controlling home appliances using their smartphones appealing or very appealing, less than half of over-55s share this sentiment, according to GlobalData, a recognized leader in providing business information and analytics.
With pharma industry ROI down, opportunity lies with innovative development and market access strategy
The pharmaceutical industry is driven by innovation in drug discovery. The age of the blockbuster drug looks to have ended, with the return on R&D spend having declined 6.4% between 2010 and 2016, according to GlobalData’s Pharmaceutical Products Database.